Epstein-Barr virus-associated haemophagocytic lympho-histiocytosis after stem cell transplantation [5]

Bone Marrow Transplantation

Volumn 38, Issue 10, 2006, Pages 709-710

  Boelens, J J ^a   Lazo, G ^b   Gaiser, J F ^a   Wulffraat, N M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Pediatric Infectious Diseases Unit   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD20 ANTIBODY; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUDARABINE; LARONIDASE; LEUKOCYTE ANTIGEN; LEVO IDURONIDASE; MELPHALAN; THIOTEPA; THYMOCYTE ANTIBODY; VIRUS DNA;

ANTIGEN DETECTION; CASE REPORT; CLINICAL FEATURE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME REPLACEMENT; EPSTEIN BARR VIRUS; FEMALE; GRAFT VERSUS HOST REACTION; HISTIOCYTOSIS; HUMAN; HURLER SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LYMPHOPROLIFERATIVE DISEASE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; VIRUS LOAD;

CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MUCOPOLYSACCHARIDOSIS I; VIREMIA;

EID: 33750555971     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705517     Document Type: Letter

References (10)

1. Cohen JI. The biology of Epstein-Barr virus: Lessons learned from the virus and the host. Curr Opin Immunol 1999; 11: 365-370.
2. Straus SE, Cohen JI, Tosato G, Meier J. NIH conference. Epstein-Barr virus infections: Biology, pathogenesis, and management. Ann Intern Med 1993; 118: 45-58.
3. Loren AW, Porter DL, Stadtmauer EA, Tsai DE. Post-transplant lymphoproliferative disorder: A review. Bone Marrow Transplant 2003; 31: 145-155.
4. Andreone P, Gramenzi A, Lorenzini S, Biselli M, Cursaro C, Pileri S et al. Posttransplantation lymphoproliferative disorders. Arch Intern Med 2003; 163: 1997-2004.
5. Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol 2002; 44: 283-294.
6. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002; 44: 259-272.
7. Sreedharan A, Bowyer S, Wallace CA, Robertson MJ, Schmidt K, Woolfrey AE et al. Macrophage activation syndrome and other systemic inflammatory conditions after BMT. Bone Marrow Transplant 2006; 37: 629-634.
8. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18: 29-33.
9. His ED, Picken MM, Alkan S. Post-transplantation lymphoproliferative disorder of the NK-cell type: A case report and review of the literature. Mod Pathol 1998; 11: 479-484.
10. Wulffraat NM, de Kleer I, Brinkman D, ten Cate R, van der Net JJ, Rijkers GT et al. Autologous stem cell transplantation for refractory juvenile idiopathic artrhitis: Current results and perspectives. Transplant Proc 2002; 34: 2925-2926.